Valley Health System
11
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.2%
2 terminated/withdrawn out of 11 trials
71.4%
-15.1% vs industry average
27%
3 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Comparison of Surgeons' Object Discernment Via Their Hands Versus Using a Robotic Surgical System That Does Not Incorporate Haptics
Role: lead
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
Role: lead
Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
Role: collaborator
Impact of a Structured Cardiac Rehabilitation Program on Cardiorespiratory Fitness in Patients With Atrial Fibrillation
Role: lead
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
Role: lead
Impact of Swaddle Blanket on Gastroesophageal Reflux
Role: lead
Ten-year Outcomes After AF Ablation
Role: lead
Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation
Role: lead
Preoperative Treatment of Patients With High Risk Thymoma
Role: lead
Comparison of Reverse Remodeling and PVI Versus CFAE and/or Linear Lesions and PVI for Persistent AF
Role: lead
Barrett's Esophagus & Gastroesophageal Reflux Disease
Role: lead
All 11 trials loaded